Signal · Supply Chain & Logistics
Beyond WHO approval, EuBiologics targets global typhoid vaccine market
What the source reported
Source-reportedEuBiologics, the Korean vaccine maker known as the largest supplier of oral cholera vaccines to global health programs for less-developed countries, is lining up its recently approved typhoid conjugate vaccine for international procurement to target an initial UNICEF allocation in the latter half of next year. EuBiologics’ typhoid conjugate vaccine, EuTYPH-C, secured the World Health Organization’s prequalification, or PQ in August, becoming the very first vaccine backed by the Research Investme
- Publication
- The Korea Herald - Business · Business News
- Published
- 27th September 2026
- Original report
- koreaherald.com
ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.
What ProcIntel recorded
ProcIntel-derived- Category
- Supply Chain & Logistics
- Geography
- South Korea
- Organisations
- None identified
- Collected
- 28th September 2026 · 06:36
Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Initial Significance Low (15.0/100). Strongest contributor: Procurement Impact (6.0/30 points). Limiting factor: Impact-Scale Specificity (0.0/10 points). Initial Confidence Very Low (17.5/100, data sufficiency: Insufficient). Strongest contributor: Source Authority (12.0/40 points). Limiting factor: Specificity (0.0/20 points).
- Strongest contributor
- Procurement Impact
- Limiting factor
- Impact-Scale Specificity